Zylyftari, Sabina
Luger, Sebastian
Blums, Kristaps
Barthelmes, Stephan
Humm, Sebastian
Baum, Hannsjörg
Meckel, Stephan
Braun, Jörg
Lichy, Gregor
Heilgeist, Andreas
Kalra, Love-Preet
Foerch, Christian
Funding for this research was provided by:
Guenther Daiss Foundation
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 5 February 2024
Accepted: 27 March 2024
First Online: 5 April 2024
Declarations
:
: The study protocol was approved by the ethics committee of the Landesärztekammer Baden-Württemberg (F2022-139). Written informed consent to participate was obtained from all surviving patients or their legal representatives before ultimate inclusion into the study. As per study protocol, before obtaining informed consent, an aliquot of the blood sample drawn in the prehospital phase for routine diagnostic purposes was taken for study purposes.
: Written informed consent for publication of anonymized patient data was obtained from all surviving patients or their legal representatives before publication.
: Prof. Foerch invented the following patent: Use of GFAP for identification of intracerebral hemorrhage (US20150247867). The other authors report no conflicts of interest.